Browsing by Author "Florensa Brichs, Lourdes"

Sort by: Order: Results:

  • Identification of two novel EPOR gene variants in primary familial polycythemia: Case report and literature review
    Lo Riso, Laura; Vargas-Parra, Gardenia; Navarro, Gemma; Arenillas Rocha, Leonor; Fernández-Ibarrondo, Lierni; Robredo, Beatriz; Ballester, Carmen; López, Bernardo; Perez-Montaña, Albert; Sampol, Antonia; Florensa Brichs, Lourdes; Besses Raebel, Carles; Duran, María Antonia; Bellosillo Paricio, Beatriz (MDPI, 2022)
    Primary familial and congenital polycythemia is a rare disease characterized by an increase in red cell mass that may be due to pathogenic variants in the EPO receptor (EPOR) gene. To date, 33 genetic variants have been ...
  • Leukemic involvement is a common feature in waldenström macroglobulinemia at diagnosis
    Montesdeoca, Sara; García Gisbert, Nieves, 1994-; Calvo, Xavier; Arenillas Rocha, Leonor; Román, David; Fernández Rodríguez, M. Concepción; Navarro, Rosa; Costan, Beatriz; Vela Ortíz, María del Carmen; Camacho Díaz, Laura; Abella Monreal, Eugenia; Colomo Saperas, Luis Alberto; Salido Galeote, Marta; Puiggros Metje, Anna Maria; Florensa Brichs, Lourdes; Espinet Solà, Blanca; Bellosillo Paricio, Beatriz; Ferrer del Álamo, Anna (MDPI, 2023)
    Waldenström Macroglobulinemia (WM) is a lymphoplasmacytic lymphoma with bone marrow (BM) involvement and IgM monoclonal gammopathy. To date, no studies have focused specifically on peripheral blood (PB) involvement. In ...
  • Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group
    Ramos, Fernando; Robledo, Cristina; Pereira, Arturo; Pedro Olive, Carme; Benito, Rocío; De Paz, Raquel; Rey, Mónica del; Insunza, Andrés; Tormo, Mar; Díez-Campelo, María; Xicoy, Blanca; Salido, Eduardo; Sánchez-del-Real, Javier; Arenillas Rocha, Leonor; Florensa Brichs, Lourdes; Luño, Elisa; Cañizo, Consuelo del; Sanz, Guillermo F.; Hernández-Rivas, Jesús María; Spanish Group for Myelodysplastic Syndromes (GESMD) (Wiley, 2017)
    The International Prognostic Scoring System and its revised form (IPSS-R) are the most widely used indices for prognostic assessment of patients with myelodysplastic syndromes (MDS), but can only partially account for the ...
  • Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features
    Calvo Gonzalo, Xavier; García Gisbert, Nieves, 1994-; Parraga, Ivonne; Gibert, Joan; Florensa Brichs, Lourdes; Andrade-Campos, Marcio; Merchan, Brayan; García-Avila, Sara; Montesdeoca, Sara; Fernández Rodríguez, M. Concepción; Salido Galeote, Marta; Puiggros Metje, Anna Maria; Espinet Solà, Blanca; Colomo Saperas, Luis Alberto; Roman-Bravo, David; Bellosillo Paricio, Beatriz; Ferrer Del Alamo, Ana; Arenillas Rocha, Leonor (American Society of Hematology, 2020)
    Oligomonocytic chronic myelomonocytic leukemia (OM-CMML) is defined as those myelodysplastic syndromes (MDSs) or myelodysplastic/myeloproliferative neoplasms, unclassifiable with relative monocytosis (≥10% monocytes) and ...
  • Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum
    Calvo González, Xavier; Roman-Bravo, David; García Gisbert, Nieves, 1994-; Rodriguez-Sevilla, Juan José; García-Avila, Sara; Florensa Brichs, Lourdes; Gibert Fernandez, Joan 1988-; Fernández Rodríguez, M. Concepción; Salido Galeote, Marta; Puiggros Metje, Anna Maria; Espinet Solà, Blanca; Colomo Saperas, Luis Alberto; Bellosillo Paricio, Beatriz; Ferrer, Ana; Arenillas Rocha, Leonor (American Society of Hematology, 2022)
    atients with oligomonocytic chronic myelomonocytic leukemia (OM-CMML) are currently classified according to the 2017 World Health Organization myelodysplastic syndromes classification. However, recent data support considering ...
  • The importance of adequate recognition of normal and dysplastic myelopoiesis for the diagnosis of myelodysplastic syndromes
    Florensa Brichs, Lourdes; Arenillas Rocha, Leonor; Calvo Gonzalo, Xavier; Pérez-Vila, Encarnación; Ferrer Del Alamo, Ana; Woessner, Soledad (Universidad de Murcia, 2019)
    The diagnosis of myelodysplastic syndromes is based on the presence of cytopenias, dysplastic morphological features on peripheral blood (PB) and bone marrow (BM), cytogenetic abnormalities and requires to rule out other ...
  • Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
    Saumell, Silvia; Solé Ristol, Francesc; Arenillas Rocha, Leonor; Montoro, Julia; Valcárcel, David; Pedro Olive, Carme; Sanzo, Carmen; Luño, Elisa; Giménez, Teresa; Arnan, Montserrat; Pomares, Helena; De Paz, Raquel; Arrizabalaga, Beatriz; Jerez, Andrés; Martínez, Ana B.; Sánchez-Castro, Judith; Rodríguez-Gambarte, Juan D.; Raya, José M.; Ríos, Eduardo; Rodríguez-Rivera, María; Espinet Solà, Blanca; Florensa Brichs, Lourdes (Public Library of Science, 2015)
    Isolated trisomy 8 is not considered presumptive evidence of myelodysplastic syndrome (MDS) in cases without minimal morphological criteria. One reason given is that trisomy 8 (+8) can be found as a constitutional mosaicism ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking